UA100377C2 - Antibodies against il-25 - Google Patents

Antibodies against il-25

Info

Publication number
UA100377C2
UA100377C2 UAA200911796A UAA200911796A UA100377C2 UA 100377 C2 UA100377 C2 UA 100377C2 UA A200911796 A UAA200911796 A UA A200911796A UA A200911796 A UAA200911796 A UA A200911796A UA 100377 C2 UA100377 C2 UA 100377C2
Authority
UA
Ukraine
Prior art keywords
antibody
treatment
relates
antibodies against
asthma
Prior art date
Application number
UAA200911796A
Other languages
English (en)
Ukrainian (uk)
Inventor
Andrew Neil James Mckenzie
Sarah Ballantyne
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of UA100377C2 publication Critical patent/UA100377C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200911796A 2007-04-18 2008-04-17 Antibodies against il-25 UA100377C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0707505.4A GB0707505D0 (en) 2007-04-18 2007-04-18 Antibodies against il-25

Publications (1)

Publication Number Publication Date
UA100377C2 true UA100377C2 (en) 2012-12-25

Family

ID=38135020

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200911796A UA100377C2 (en) 2007-04-18 2008-04-17 Antibodies against il-25

Country Status (32)

Country Link
US (1) US8206717B2 (ru)
EP (1) EP2144934B1 (ru)
JP (1) JP5366930B2 (ru)
KR (1) KR101605861B1 (ru)
CN (1) CN101711256B (ru)
AU (1) AU2008240436B2 (ru)
BR (1) BRPI0810418A8 (ru)
CA (1) CA2684492C (ru)
CO (1) CO6260104A2 (ru)
CR (1) CR11079A (ru)
CY (1) CY1118244T1 (ru)
DK (1) DK2144934T3 (ru)
EA (1) EA018073B1 (ru)
EC (1) ECSP099726A (ru)
ES (1) ES2604255T3 (ru)
GB (1) GB0707505D0 (ru)
GT (1) GT200900271A (ru)
HN (1) HN2009003038A (ru)
HR (1) HRP20161548T1 (ru)
HU (1) HUE030935T2 (ru)
IL (1) IL201552A (ru)
LT (1) LT2144934T (ru)
MX (1) MX2009011234A (ru)
MY (1) MY148451A (ru)
NI (1) NI200900189A (ru)
NZ (1) NZ581178A (ru)
PL (1) PL2144934T3 (ru)
PT (1) PT2144934T (ru)
RS (1) RS55401B1 (ru)
SI (1) SI2144934T1 (ru)
UA (1) UA100377C2 (ru)
WO (1) WO2008129263A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25
US8574582B2 (en) * 2008-10-31 2013-11-05 Janssen Biotech, Inc. Methods for mediating fibrotic response
GB0905972D0 (en) 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
EP2477647B1 (en) 2009-09-14 2016-01-13 The Regents of the University of Colorado Modulation of yeast-based immunotherapy products and responses
SG184195A1 (en) * 2010-03-30 2012-11-29 Janssen Biotech Inc Humanized il-25 antibodies
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN103792375B (zh) * 2014-01-29 2017-07-07 华中科技大学同济医学院附属同济医院 外周血白细胞介素25水平在哮喘分型中的应用及分型方法
SG10201913084PA (en) 2014-09-23 2020-03-30 Regeneron Pharma Anti-il-25 antibodies and uses thereof
KR102477922B1 (ko) * 2016-03-16 2022-12-14 아베오미 코포레이션 Il-25에 대한 중화 모노클로날 항체 및 그의 용도
WO2018017864A2 (en) * 2016-07-20 2018-01-25 Oncomed Pharmaceuticals, Inc. Pvrig-binding agents and uses thereof
WO2018018082A1 (en) 2016-07-26 2018-02-01 The Australian National University Immunostimulatory compositions and uses therefor
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
US20210332123A1 (en) * 2018-11-19 2021-10-28 Suzhou Kanova Biopharmaceutical Co., Ltd. Anti-il-25 antibodies and use thereof
GB202018015D0 (en) 2020-11-16 2020-12-30 Res & Innovation Uk Composition and methods for the treatment of intestinal cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
CN1289668C (zh) * 2003-06-12 2006-12-13 北京安波特基因工程技术有限公司 一种用于抗体改形的体外分子定向进化方法
EP1863520B1 (en) 2005-03-08 2014-12-31 Aptose Biosciences Inc. Use of interleukin 17e for the treatment of cancer
CA2658833A1 (en) 2005-10-06 2007-04-19 Baylor Research Institute Compositions and methods for the treatment of cancer
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25

Also Published As

Publication number Publication date
RS55401B1 (sr) 2017-04-28
CO6260104A2 (es) 2011-03-22
EA200901421A1 (ru) 2010-10-29
HN2009003038A (es) 2011-11-11
NZ581178A (en) 2012-01-12
ES2604255T3 (es) 2017-03-06
JP5366930B2 (ja) 2013-12-11
DK2144934T3 (en) 2016-12-12
IL201552A0 (en) 2010-05-31
AU2008240436B2 (en) 2011-03-17
IL201552A (en) 2015-08-31
MX2009011234A (es) 2010-02-18
BRPI0810418A8 (pt) 2018-12-11
AU2008240436A1 (en) 2008-10-30
NI200900189A (es) 2010-09-13
EP2144934B1 (en) 2016-08-24
US20100129380A1 (en) 2010-05-27
WO2008129263A1 (en) 2008-10-30
CN101711256B (zh) 2013-10-16
EA018073B1 (ru) 2013-05-30
HUE030935T2 (en) 2017-06-28
PT2144934T (pt) 2016-12-02
HRP20161548T1 (hr) 2016-12-30
CY1118244T1 (el) 2017-06-28
CA2684492C (en) 2015-11-24
KR20100021569A (ko) 2010-02-25
BRPI0810418A2 (pt) 2014-10-14
CN101711256A (zh) 2010-05-19
SI2144934T1 (sl) 2016-12-30
LT2144934T (lt) 2016-12-27
KR101605861B1 (ko) 2016-03-24
MY148451A (en) 2013-04-30
US8206717B2 (en) 2012-06-26
PL2144934T3 (pl) 2017-07-31
CA2684492A1 (en) 2008-10-30
CR11079A (es) 2010-03-03
ECSP099726A (es) 2010-01-29
EP2144934A1 (en) 2010-01-20
JP2010524450A (ja) 2010-07-22
GT200900271A (es) 2010-11-03
GB0707505D0 (en) 2007-05-30

Similar Documents

Publication Publication Date Title
UA100377C2 (en) Antibodies against il-25
UA95478C2 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТ с-Kit
UA116873C2 (uk) Антитіло, яке зв'язується з ox40
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
UA95068C2 (ru) Антиген-связующая молекула, которая связывает egfr, вектор, который ее кодирует, и их применение
MX2009006891A (es) Anticuerpos cd44.
UA115439C2 (uk) Гуманізоване антитіло, яке розпізнає альфа-синуклеїн
MX369148B (es) Agentes de unión kir3dl2.
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
UA114891C2 (uk) ІЗОЛЬОВАНЕ АНТИТІЛО ЛЮДИНИ, ЯКЕ СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З АНГІОПОЕТИНПОДІБНИМ БІЛКОМ 3 ЛЮДИНИ (hАNGPTL3), ТА ЙОГО ЗАСТОСУВАННЯ
UA115657C2 (uk) Виділене антитіло, яке зв'язується з одним або декількома епітопами тау, фармацевтична композиція, що його містить, спосіб лікування та спосіб діагностики хвороби альцгеймера на основі виділеного антитіла
UA115540C2 (uk) Антитіло до il-36r
EA201492101A1 (ru) Антитела против fcrn
MX2009003306A (es) Anticuerpos humanos que se unen a cxcr4 y sus usos.
WO2009112245A9 (en) Antibody against the csf-1 r
MX2010000537A (es) Anticuerpos monoclonales contra glipicano-3.
MX2009004532A (es) Composiciones y metodos para unir esfingosina-1-fosfato.
UA114902C2 (uk) Виділене антитіло, яке зв'язує парний спіральний філамент-тау (псф-тау), та фармацевтична композиція, що містить таке антитіло
PH12015501505B1 (en) Antibodies that bind to tl1a and their uses
MY150246A (en) Alpha 5 - beta 1 antibodies and their uses
CY1116313T1 (el) Αντισωματα εναντιον il-25
CL2008003784A1 (es) Anticuerpo humanizado anti proteina e2 del virus de la hepatitis c o un fragmento de union; acido nucleico que lo codifica; vector y celula huesped que comprenden dicho acido nucleico; metodo para producir el anticuerpo; composicion farmaceutica que comprende el anticuerpo
EA201892184A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора
IN2012DN00797A (ru)
UA105073C2 (ru) Антитело против фракталкина, композиция и способ лечения воспалительных нарушений